Pulse Biosciences (PLSE) Accounts Payables (2020 - 2025)
Historic Accounts Payables for Pulse Biosciences (PLSE) over the last 6 years, with Q3 2025 value amounting to $3.0 million.
- Pulse Biosciences' Accounts Payables rose 7243.78% to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 million, marking a year-over-year increase of 7243.78%. This contributed to the annual value of $1.7 million for FY2024, which is 887.8% down from last year.
- Latest data reveals that Pulse Biosciences reported Accounts Payables of $3.0 million as of Q3 2025, which was up 7243.78% from $2.7 million recorded in Q2 2025.
- Pulse Biosciences' Accounts Payables' 5-year high stood at $3.5 million during Q1 2022, with a 5-year trough of $1.4 million in Q3 2023.
- Over the past 5 years, Pulse Biosciences' median Accounts Payables value was $1.9 million (recorded in 2022), while the average stood at $2.1 million.
- In the last 5 years, Pulse Biosciences' Accounts Payables skyrocketed by 8959.03% in 2021 and then plummeted by 3803.79% in 2023.
- Pulse Biosciences' Accounts Payables (Quarter) stood at $1.8 million in 2021, then fell by 14.32% to $1.6 million in 2022, then rose by 16.72% to $1.8 million in 2023, then fell by 8.88% to $1.7 million in 2024, then soared by 78.0% to $3.0 million in 2025.
- Its Accounts Payables stands at $3.0 million for Q3 2025, versus $2.7 million for Q2 2025 and $2.4 million for Q1 2025.